Health Professional Radio - Podcast

Dr. Craig Rayner, president of Certara’s Integrated Drug Development and Strategic Consulting Services discusses the COVID-19 Pharmacology Online Resource Center funded by the Bill & Melinda Gates Foundation and the programs they are working on to accelerate the treatment for COVID-19.

Justin Williams, founder and CEO of Noteworth, a healthcare delivery platform, discusses the biggest issues facing telehealth today, particularly in rural areas, how revenue is suffering but telehealth is bringing over 70 percent of practices online and in contact with patients, avoiding staff cuts. He and his team have launched a specific platform to solely monitor and screen COVID-19 and is currently tracking over 2,000 COVID patients.

June 12, 2020, is International NASH Day and Wayne Eskridge, cirrhosis patient and founder of the Fatty Liver Foundation and Donna Cryer, liver transplant patient and the president and CEO of the Global Liver Institute discuss non-alcoholic steatohepatitis (NASH) and concerns surrounding NASH during COVID-19.

Physician, professor, and Medical Futurist, Dr. Dan O'Brien, discusses CRISPR technology and its application in detecting COVID-19 and how it's the key to re-opening society.

Dr. Aaron Katz, MD, Chairman of Urology at NYU Winthrop Hospital and Professor of Urology NYU School of Medicine, discusses the Oncotype DX Genomic Prostate Score® (GPS™) test and how it is used by physicians and he covers the Abstract from the American Urological Association (AUA) 2020 meeting titled "A 17 -Gene RT RT-PCR Prostate Assay: Clinical Experience in 33,000 Patients with Clinically Low-Risk Prostate Cancer"

Returning guest, rheumatologist and gout expert, Dr. N. Lawrence Edwards discusses the new 2020 American College of Rheumatology (ACR) Guideline for the Management of Gout. Dr. Edwards is also the chairman of the Gout Education Society, a nonprofit organization dedicated to raising awareness of gout and providing free educational materials to medical professionals and patients or caregivers.

Alistair Fulton, Vice President and General Manager of Semtech's Wireless and Sensing Products Group discusses Semtech's response to the COVID-19 pandemic and how their customers worldwide have integrated its LoRa® technology with Alibaba Cloud’s and Tencent Cloud’s platforms to deploy IoT-based monitoring applications for quarantine scenarios in China, while smart temperature sensors are also enabling healthcare workers in Italy to identify individuals with a high temperature. These are just a few examples being done by high-tech companies such as Semtech.

Dr. James Wheless, MD, Co-Director of the Le Bonheur Comprehensive Epilepsy Program discusses how sleep deprivation due to stress and anxiety over the pandemic can trigger an increase in breakthrough seizure frequency, intensity, and length. He offers tips for talking to patients about the importance of sleep health, the importance of epilepsy action plans, the role of rescue medications to manage overall health and limit hospital visits, and how telehealth consultations lend themselves especially well to reviewing proactive epilepsy care plans with patients and caregivers.

Dr. Emily Lopes, a Gastroenterology Clinical and Research Fellow at Massachusetts General Hospital discusses the Abstract presentation from Digestive Disease Week® (DDW) 2020 titled "Dietary gluten intake and risk of inflammatory bowel disease among US women without celiac disease".

Dr. Andrew Chan, Chief of Clinical and Translational Epidemiology Unit at Massachusetts General Hospital discusses the presentation from Digestive Disease Week® titled "Physical activity is associated with a lower risk of esophageal cancer".

Dr. Keyan Salari, a urologic oncologist at Massachusetts General Hospital and instructor in surgery, Harvard Medical School discusses his Abstract presentation from the American Urological Association (AUA2020) Annual Meeting titled "5-alpha reductase inhibitors and risk of overall and fatal bladder cancer".

Returning guest, award-winning author, speaker, and international health advocate Silvie Beljanski discusses several tips on strengthening immunity and obtaining wellness balance. She talks about how she views COVID-19 as an environmental toxin, how the war on cancer is impacted by the focus and resources applied to COVID-19, and what we need to know about integrative medicine when considering experimental COVID drug treatments.

Dr. Raymond Liu, MD, discusses a new research paper that details how Kaiser Permanente Northern California (KPNC) quickly ramped up its existing telehealth oncology program at the onset of the COVID-19 pandemic. The paper published in JCO Oncology Practice, titled “Telehealth in Oncology During the COVID19 Outbreak: Bringing the house call back virtually,” offers insights for medical centers and health systems throughout the country that are facing similar challenges.

Dr. Jacob Sands, a thoracic medical oncologist at the Dana-Farber Cancer Institute and Instructor of Medicine, Harvard Medical School, discusses advanced lung cancer and a new initiative by Merck in collaboration with the GO2 Foundation for Lung Cancer called "Worth the Fight: Taking on Lung Cancer", that offers support and resources to people impacted by advanced lung cancer and empower them to take an active role in their cancer care.

Returning guest, Ken Cahill, CEO of SilverCloud Health, discusses how they are responding to the coronavirus pandemic with the increased demand for effective mental health treatment. SilverCloud offers an industry-leading, clinically-validated digital mental health platform used by over 300 organizations around the world including Optum Health and 70% of the UK’s NHS.

Dr. Michael Dougan, gastroenterologist/internist at Massachusetts General Hospital discusses the research presented at Digestive Disease Week® (DDW) 2020 titled "Immune checkpoint inhibitor-associated celiac disease".

Dr. Zoe Memel, MD, PG1, Department of Medicine, Massachusetts General Hospital discusses the research presented at Digestive Disease Week® (DDW) 2020 titled "Aspirin use is associated with a reduced incidence of hepatocellular carcinoma: a systematic review and meta-analysis"

Dr. Marcia Brose, Associate Professor at the University of Pennsylvania School of Medicine discusses the role of cancer genomic testing and Neurotrophic Tropomyosin Receptor Kinase (NTRK) gene fusions. NTRK gene fusions can cause cancer cells to multiply, form tumors, and are more common in certain thyroid and colon cancer subtypes. Bayer and Neogenomics Inc. launched the Test4TRK™ program to offer genomic cancer testing for NTRK gene fusions at no cost for patients who meet certain criteria.

Dr. Robert Giugliano, MD, discusses data released from the FOURIER study, an analysis evaluating patient-reported cognition in high-risk heart disease patients, including patients achieving low levels of LDL-cholesterol after an average of two years of treatment. The data were published in the "Journal of the American College of Cardiology" May 2020

.Jodi Parker, a cancer advocate and patient living with advanced lung cancer shares her journey and her involvement with Merck's and the GO2 Foundation for Lung Cancer's new patient awareness initiative "Worth the Fight: Taking on Lung Cancer" that offers support and resources to people impacted by advanced lung cancer and empower them to take an active role in their cancer care.